<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Persson Walls | Activity</title>
	<link>http://toxicdolls.com/members/factpvc0/activity/</link>
	<atom:link href="http://toxicdolls.com/members/factpvc0/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Persson Walls.</description>
	<lastBuildDate>Sun, 08 Nov 2026 17:11:27 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">563f0c0a058de14b8369df487284fe10</guid>
				<title>Persson Walls posted an update: Objective To examine the efficacy, safety, and tolerability [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/59992/</link>
				<pubDate>Fri, 18 Jul 2025 08:10:31 +0000</pubDate>

									<content:encoded><![CDATA[<p>Objective To examine the efficacy, safety, and tolerability of methylphenidate extended-release orally disintegrating tablets (MPH XR-ODT) for the treatment of attention-deficit/hyperactivity disorder (ADHD) during the open-label dose-optimization/stabilization period of a phase 3 laboratory classroom study. Methods Children (6-12 years) diagnosed&hellip;<span class="activity-read-more" id="activity-read-more-59992"><a href="http://toxicdolls.com/activity-2/p/59992/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1d6c48ab0f56a333c837975c93e8f159</guid>
				<title>Persson Walls posted an update: The fecal microbiota in pancreatic ductal adenocarcinoma [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/56983/</link>
				<pubDate>Wed, 16 Jul 2025 08:53:35 +0000</pubDate>

									<content:encoded><![CDATA[<p>The fecal microbiota in pancreatic ductal adenocarcinoma (PDAC) and in autoimmune pancreatitis (AIP) patients remains largely unknown. We aimed to characterize the fecal microbiota in patients with PDAC and AIP, and explore the possibility of fecal microbial biomarkers for distinguishing PDAC and AIP.</p>
<p> 32 patients with PDAC, 32 patients&hellip;<span class="activity-read-more" id="activity-read-more-56983"><a href="http://toxicdolls.com/activity-2/p/56983/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d415868ddb80f8048a186e647ae3580</guid>
				<title>Persson Walls posted an update: Candidiasis (e.g., oral, gastrointestinal, vaginal, urinary [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/43513/</link>
				<pubDate>Fri, 11 Jul 2025 08:43:07 +0000</pubDate>

									<content:encoded><![CDATA[<p>Candidiasis (e.g., oral, gastrointestinal, vaginal, urinary tract, systemic) is a worldwide growing problem, since antifungal resistance and immunosuppression states are rising. To address this problem, very few drugs are available for the treatment of Candida spp. infections. <a href="https://www.selleckchem.com/products/dibutyryl-camp-bucladesine.html" rel="nofollow ugc">see more</a> Therefore, novel therapeutic strategies are urgently required.&hellip;<span class="activity-read-more" id="activity-read-more-43513"><a href="http://toxicdolls.com/activity-2/p/43513/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ce48999129e410a18bdf226de3bc5a34</guid>
				<title>Persson Walls became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/40262/</link>
				<pubDate>Thu, 10 Jul 2025 09:03:23 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>